IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-03-10 AccNo: 0001493152-16-007944 Size: 653 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-03-03 AccNo: 0001493152-16-007813 Size: 4 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0000919574-16-010963 Size: 96 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001546927-16-000418 Size: 15 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001546927-16-000414 Size: 15 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 内部交易: 2016-02-01,CFO,BOLL ANDREW R. ,期权,15000普通股, $3.68
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-01-25 AccNo: 0001493152-16-006916 Size: 608 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangemen...
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-01-06 AccNo: 0001493152-16-006632 Size: 4 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2015-12-28 AccNo: 0001493152-15-006428 Size: 26 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive Agreement 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2015-12-28 AccNo: 0001493152-15-006427 Size: 199 KB 网页链接